R&D / revenue moved 7319 bp lower
R&D / revenue changed -7319 basis points from the comparable as-filed period.
166.38%→93.20%3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ADCT financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow margin moved 6983 bp higher
Free-cash-flow margin changed +6983 basis points from the comparable as-filed period.
-133.19%→-63.36%3 prior comparisons
Operating cash-flow margin moved 6983 bp higher
Operating cash-flow margin changed +6983 basis points from the comparable as-filed period.
-133.19%→-63.36%3 prior comparisons
Shares outstanding increased 13.5%
Shares outstanding changed +13.5% from the comparable as-filed period. The change ranks at the 14th percentile of 7 prior comparable changes.
112,499,395→127,667,6957 prior comparisons
Revenue increased 3.0%
Revenue changed +3.0% from the comparable as-filed period.
$18.1M→$18.6M3 prior comparisons
Capex / revenue moved 0 bp unchanged
Capex / revenue changed +0 basis points from the comparable as-filed period.
0.00%→0.00%3 prior comparisons
Capital expenditure changed across a zero base
Capital expenditure changed from 0 to 0 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
$0→$04 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.